Phase 2 Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are scheduled to have a minimally invasive esophageal (food pipe) surgery for cancer, abnormal cell changes in the food pipe, or problems with how the food pipe moves food
- People who are 18 years of age or older
- People who are able to understand the study and are willing to sign a consent form agreeing to take part
Who may not be able to join:
- People who have a history of a heart rhythm problem called atrial fibrillation (either ongoing or occasional) or a related condition called atrial flutter
- People who have had a serious reaction to a heart medication called amiodarone in the past, or for whom that medication is not considered safe (for example, due to lung, liver, or thyroid problems)
- People who are already taking amiodarone as a regular daily medication before surgery
- People who develop an irregular heart rhythm called atrial fibrillation during the surgery itself
- People who are pregnant (a negative pregnancy test is required on the day of surgery for people who could become pregnant)
- People who are currently breastfeeding or chest feeding
- People whose esophageal surgery was started but not completed
- People whose heart electrical reading (called an ECG or EKG), taken within the last 30 days, shows a certain measurement called QTcF above 500 when their heart rate is between 60 and 100 beats per minute
- People with a resting heart rate between 50 and 59 beats per minute may require additional heart testing before the trial site can confirm eligibility — this involves checking whether the heart rate rises sufficiently during light exercise or a formal stress test (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Development of atrial fibrillation (AF), or completion of seven-day course of amiodarone
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.